Vaccines News
-
Devising a viable global strategy to combat Cholera
Vaccines | Opinion | 0 Comment | 31 May, 2023
For reasons not yet fully understood, beginning in 2022 the world experienced an unprecedented surge in cholera outbreak...Read more
-
Korea's International Vaccine Institute establishes Joint Research Institution in China
Vaccines | News | 0 Comment | 23 May, 2023
South Korea-based International Vaccine Institute (IVI) has sigend a Memorandum of Understanding (MoU) with Nankai ...Read more
-
China approves two COVID-19 vaccine trials against most recent circulating XBB variants
Vaccines | News | 0 Comment | 22 May, 2023
Recombinant bivalent COVID-19 protein vaccine (Sf9 cells) and recombinant trivalent COVID-19 trimeric protein vaccine (S...Read more
-
World’s first and only oral cholera vaccine in LDPE unidose pack launches in India
Vaccines | News | 0 Comment | 12 May, 2023
TechInvention Lifecare in India, has partnered with Eubiologics Co. in South Korea, to launch Euv...Read more
-
International partnership supports vaccine research to prevent future outbreaks
Vaccines | News | 0 Comment | 08 May, 2023
Jean-Yves Duclos, Minister of Health, and Harjit S. Sajjan, Minister of International Development and Minister responsib...Read more
-
Korea begins clinical development of new low-cost oral cholera vaccine in capsule form
Vaccines | News | 0 Comment | 01 May, 2023
The International Vaccine Institute (IVI), based in South Korea, has begun clinical development of DuoChol, a new low-co...Read more
-
US FDA approves Pfizer’s 20-valent Pneumococcal Conjugate Vaccine for children
Vaccines | News | 0 Comment | 28 Apr, 2023
American pharmaceutical firm Pfizer Inc. has announced that the US Food and Drug Administration (FDA) has approved PREVN...Read more
-
Survey: One-third of COVID-19 vulnerable groups avoid booster shots
Vaccines | Company results | 2 Comment | 25 Apr, 2023
The results from a new YouGov survey called, ‘What’s Next for COVID-19 in Singapore?’, commissioned by...Read more
-
Singapore unveils new approach to aid pneumococcal vaccine development
Vaccines | News | 0 Comment | 20 Apr, 2023
Many disease-causing bacteria like Streptococcus pneumoniae (S. pneumoniae) are encased in a sugar layer called the caps...Read more
-
BioMinhai and Biotis to promote development of vaccine industry in Indonesia
Vaccines | News | 0 Comment | 08 Apr, 2023
Beijing Minhai Biotechnology Co., (BioMinhai), a wholly-owned subsidiary of China-based Shenzhen Kangtai Biological Prod...Read more
-
Sanofi opens state-of-the-art facility in US for pandemic flu vaccines production
Vaccines | News | 0 Comment | 06 Apr, 2023
Sanofi and the Biomedical Advanced Research and Development Authority (BARDA), part of the Administration for Strategic ...Read more
-
Korean firm DxVx completes Phase 1a clinical trial of novel cancer vaccine
Vaccines | News | 0 Comment | 03 Apr, 2023
DXVX has announced that its affiliated company Oxford Vacmedix (OVM) has completed Phase 1a trial of cancer vaccine and ...Read more
-
Australian biotech behemoth CSL unveils new vaccine R&D facility in US
Vaccines | News | 0 Comment | 28 Mar, 2023
Australian biotech firm CSL recently celebrated the official opening of the company's new state-of-the-art research and ...Read more
-
New funding by NZ to boost RNA research into vaccines & healthcare
Vaccines | News | 0 Comment | 27 Mar, 2023
Victoria University of Wellington and University of Auckland, in New Zealand (NZ) have been named as co-hosts of a ...Read more
-
Singapore gives nod to Pfizer’s Pneumococcal 20-valent conjugate vaccine for adults
Vaccines | News | 0 Comment | 22 Mar, 2023
American pharmaceutical firm Pfizer has announced that the Singapore Health Sciences Authority (HSA) has approved its 20...Read more
-
China's first personalised neoantigen-targeted cancer vaccine gets clinical trial approval
Vaccines | News | 0 Comment | 17 Mar, 2023
Likang Life Sciences has received National Medical Products Administration (NMPA) approval for the clinical trial of its...Read more
-
Vaccines | News | 0 Comment | 20 Mar, 2023
RVAC Medicines, Inc., a messenger RNA (mRNA) technology company with its global headquarters in Singapore, has anno...Read more
-
Takeda’s dengue vaccine receives first approval in Latin America
Vaccines | News | 0 Comment | 15 Mar, 2023
Japanese pharmaceutical company Takeda's dengue vaccine, QDENGA (Dengue Tetravalent Vaccine [Live, Attenuated...Read more
